Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Mochida to Increase MRs to 750 by FY2009
April 16, 2007
- TOPICS／Abilify Receives PSJ Award: Otsuka
April 16, 2007
- Industry's Highest Growth Rate Recorded Twice in 2 Years: NBI
April 16, 2007
- Use of 9 Reagents for Pancreatic Islet Transplantations Restricted
April 16, 2007
- Janssen's Sales Drop 11.8% Due to NHI Price Cuts
April 16, 2007
- MEDICAL DEVICE NEWS IN BRIEF
April 16, 2007
- BUSINESS NEWS IN BRIEF
April 16, 2007
- 26 Complaints Received Regarding Supply of Generics in 1 Year
April 16, 2007
- Abnormal Behavior Reported from 128 Patients after Taking Tamiflu: Korosho
April 16, 2007
- PSJ Luncheon Seminar
April 16, 2007
- Chugai's Grants Go to 3 Institutions Whose Researchers Participate in Tamiflu Survey
April 16, 2007
- Daiichi Sankyo Healthcare to Focus on Switch OTC Drugs
April 16, 2007
- Permax Withdrawn from US Market
April 16, 2007
- TOPICS／ACNielsen, So-net M3 to Start Radar"Track Service
April 16, 2007
- Data Protection Period Extended to 8 Years
April 16, 2007
- Great Precautions Needed in Revising PMDA's Employment Rule: Health Minister
April 16, 2007
- Alfresa Aims at 70% Share for Drugs for Narcolepsy with Modafinil
April 9, 2007
- Kobayashi Kako to Distribute Generics in Asian Countries
April 9, 2007
- Rep Track Survey: Anti-Allergy Drugs Enter Pollinosis Season
April 9, 2007
- GENERIC NEWS IN BRIEF
April 9, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…